SBT_New August 2022 LOGO
Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors
15 mars 2023 08h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
14 mars 2023 08h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools to Present at 43rd Annual Cowen Health Care Conference
01 mars 2023 16h05 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21 févr. 2023 08h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that the Compensation Committee of its Board of Directors, which is composed...
SBT_New August 2022 LOGO
Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook
14 févr. 2023 16h05 HE | Standard BioTools Inc.
Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP revenues of $97.9 million and core product...
SBT_New August 2022 LOGO
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results
31 janv. 2023 08h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
09 janv. 2023 08h30 HE | Standard BioTools Inc.
Continued commercial and strategic execution delivers sequential core revenue growth of 4%–9% to $26 million–$27 million in Q4 2022 for full year total of approximately $94 million–$95 million ...
SBT_New August 2022 LOGO
Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer
03 janv. 2023 08h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools Authorizes up to $20 Million of Share Repurchases
28 nov. 2022 08h30 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today...
SBT_New August 2022 LOGO
Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22 nov. 2022 09h20 HE | Standard BioTools Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that the Compensation Committee of its Board of Directors, which is composed...